Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome

Glioma, Malignant Clinical Trial

Official title:

Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04562077
• Other study ID #: surgery in glioma
• Status: Not yet recruiting
• Start date: October 2020
• Est. completion date: November 2021

Study information

• Verified date: September 2020
• Source: Assiut University
• Contact: Mohamad S Waer
• Phone: 00201066479705
• Email: mohamadswaer[@]icloud.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

role of surgery in treatment of recurrent brain glioma prognostic factors and outcome measures Role of surgery : In patients with Grade I gliomas, such as pilocytic astrocytomas, resection is potentially curative.

For more diffuse invasive gliomas (Grade II or higher), initial management typically includes maximal safe resection when possible.

Increasing evidence supports an association between extent of resection and prolonged progression-free and overall survival for patients with diffuse gliomas of all types and grades Many studies reported that more that 90%of patients with glioma showed recurrence at the orginal tumor location.

Review the outcomes of re-operation in treatment of recurrent brain gliomas To determine the prognostic factors which can predict which patient would benefit from multiple surgery .

Trail to Improve the outcome of these patients and decrease rate of complications

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 25
• Est. completion date: November 2021
• Est. primary completion date: November 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patient previously operated and documented as a glioma with clinical and neuroimaging and pathological evidences.

Patients who will undergo re-operation for treatment of a recurrent brain glioma at the time of study(one year) Histological types : Different histological types of glioma.

Exclusion Criteria:

• patients has brain glioma that is de novo patients who are unfit for any neurosurgical interventions. Multicentric recurrent glioma.

Related Conditions & MeSH terms

• Glioma
• Glioma, Malignant
• Recurrent Glioma

Locations

Country	Name	City	State
Egypt	Assuit University Hospitals	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	karnofsky performance status	A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Status scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities. Karnofsky Performance Status may be used to determine a patient's prognosis, to measure changes in a patient's ability to function, or to decide if a patient could be included in a clinical trial. Also called KPS.	1year